Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Diabetes Mellitus (D003920)
..Starting node
..expand
Diabetes Mellitus, Type 2 (D003924)

       Child Nodes:
........expandDiabetes Mellitus, Lipoatrophic (D003923) Child1
........expandDiabetes Mellitus, Noninsulin-Dependent, 1 (C563359)
........expandDiabetes Mellitus, Noninsulin-Dependent, 2 (C563323)
........expandDiabetes Mellitus, Noninsulin-Dependent, 3 (C566342)
........expandDiabetes Mellitus, Noninsulin-Dependent, Type 4 (C564299)
........expandDiabetes Mellitus, Type II, Autosomal Dominant (C562773)
........expandMason-Type Diabetes (C562772)
........expandMaturity-Onset Diabetes of the Young, Type 1 (C565101)
........expandMaturity-Onset Diabetes of the Young, Type 2 (C564219)
........expandMaturity-Onset Diabetes of the Young, Type 3 (C563933)
........expandMaturity-Onset Diabetes of the Young, Type 4 (C563451)
........expandMaturity-Onset Diabetes of the Young, Type 8, with Exocrine Dysfunction (C565225)
........expandMaturity-Onset Diabetes Of The Young, Type 9 (C567393)
........expandMODY, Type 6 (C565231)
........expandNoninsulin-dependent diabetes mellitus with deafness (C536246)
........expandRenal cysts and diabetes syndrome (C535520)



 Sister Nodes: 
..expand6q24-Related Transient Neonatal Diabetes Mellitus (C579872)
..expandAlaninuria with Microcephaly, Dwarfism, Enamel Hypoplasia, and Diabetes Mellitus (C565968)
..expandAtherosclerosis, Premature, with Deafness, Nephropathy, Diabetes Mellitus, Photomyoclonus, and Degenerative Neurologic Disease (C565928)
..expandDevelopmental Delay, Epilepsy, and Neonatal Diabetes (C565253)
..expandDiabetes Complications (D048909) Child23
..expandDiabetes Mellitus, Congenital Autoimmune (C565730)
..expandDiabetes Mellitus, Experimental (D003921)
..expandDiabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans (C562710)
..expandDiabetes Mellitus, Neonatal, with Congenital Hypothyroidism (C565705)
..expandDiabetes Mellitus, Permanent Neonatal (C563425)
..expandDiabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis (C563796)
..expandDiabetes Mellitus, Permanent Neonatal, With Neurologic Features (C563424)
..expandDiabetes Mellitus, Transient Neonatal, 1 (C563322)
..expandDiabetes Mellitus, Transient Neonatal, 2 (C563672)
..expandDiabetes Mellitus, Transient Neonatal, 3 (C566432)
..expandDiabetes Mellitus, Type 1 (D003922) Child26
..expandDiabetes Mellitus, Type 2 (D003924) Child17
..expandDiabetes, Gestational (D016640) Child5
..expandDiabetic Ketoacidosis (D016883)
..expandDonohue Syndrome (D056731) Child1
..expandFeigenbaum Bergeron Richardson syndrome (C536178)
..expandFurukawa Takagi Nakao syndrome (C538193)
..expandHerrmann syndrome (C538113)
..expandHyperproinsulinemia (C562776)
..expandLipoatrophy with diabetes, hepatic steatosis, cardiomyopathy, and leukomelanodermic papules (C535905)
..expandLymphedema-Distichiasis Syndrome with Renal Disease and Diabetes Mellitus (C567188)
..expandMartinez-Frias Syndrome (C563346)
..expandMATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10 (OMIM:613370)
..expandMATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11 (OMIM:613375)
..expandMaturity-Onset Diabetes of the Young, Type 7 (C566466)
..expandMitchell-Riley Syndrome (C567570)
..expandMitochondrial Myopathy with Diabetes (C564026)
..expandMuscular Atrophy, Ataxia, Retinitis Pigmentosa, and Diabetes Mellitus (C562774)
..expandPancreatic beta cell agenesis with neonatal diabetes mellitus (C538111)
..expandPancreatic Hypoplasia, Congenital, with Diabetes Mellitus and Congenital Heart Disease (C564011)
..expandPrediabetic State (D011236)
..expandPremature aging, Okamoto type (C535270)
..expandThiamine responsive megaloblastic anemia syndrome (C536510)
..expandWolfram Syndrome, Mitochondrial Form (C564012)
..expandWoodhouse Sakati syndrome (C536742)
..expandYorifuji Okuno syndrome (C536714)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:3307
Name:Diabetes Mellitus, Type 2
Definition:A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Alternative IDs:OMIM:125853
ParentIDs:MESH:D003920
TreeNumbers:C18.452.394.750.149 |C19.246.300
Synonyms:Adult-Onset Diabetes Mellitus |Diabetes Mellitus, Adult Onset |Diabetes Mellitus, Adult-Onset |Diabetes Mellitus, Ketosis Resistant |Diabetes Mellitus, Ketosis-Resistant |Diabetes Mellitus, Maturity Onset |Diabetes Mellitus, Maturity-Onset |Diabetes Mellitus, N
Slim Mappings:Endocrine system disease|Metabolic disease
Reference: MedGen: D003924
MeSH: D003924
OMIM: 125853;

Genes: ABCC8; AKT2; CDKAL1; ENPP1; GCGR; GCK; GPD2; HMGA1; HNF1A; HNF1B; HNF4A; IGF2BP2; IL6; IRS1; IRS2; KCNJ11; LIPC; MAPK8IP1; MTNR1B; NEUROD1; PAX4; PDX1; PPARG; PTPN1; RETN; SLC2A2; SLC30A8; TCF7L2; WFS1;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0003584Late onset
3 HP:0000855Insulin resistance
4 HP:0005978Type II diabetes mellitus
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_001287174.1(ABCC8):c.4138C>T (p.Arg1380Cys)6833ABCC8Pathogenic137852673RCV000009674; RCV000009673; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C1835887,OMIM:610374111741746217417462NM_001287174.1:c.4138C>TNP_001274103.1:p.Arg1380CysNC_000011.9:g.17417462G>A,NC_000011.9:g.17417462G>TOMIM Allelic Variant:600509.0019C0011860 125853 Diabetes mellitus type 2; C1835887 610374 Transient neonatal diabetes mellitus 2
NM_001287174.1(ABCC8):c.1744C>G (p.Leu582Val)6833ABCC8Pathogenic137852674RCV000009676; RCV000009675; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C1835887,OMIM:610374111745243417452434NM_001287174.1:c.1744C>GNP_001274103.1:p.Leu582ValNC_000011.9:g.17452434G>COMIM Allelic Variant:600509.0020C0011860 125853 Diabetes mellitus type 2; C1835887 610374 Transient neonatal diabetes mellitus 2
NM_001626.5(AKT2):c.821G>A (p.Arg274His)208AKT2Pathogenic121434593RCV000015016; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006194074388640743886NM_001626.5:c.821G>ANP_001617.1:p.Arg274HisNC_000019.9:g.40743886C>TOMIM Allelic Variant:164731.0001C0011860 125853 Diabetes mellitus type 2
NM_023083.3(CAPN10):c.471-176G>A11132CAPN10risk factor3792267RCV000005398; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540062241531174241531174NM_023083.3:c.471-176G>ANC_000002.11:g.241531174G>AOMIM Allelic Variant:605286.0001C0011860 125853 Diabetes mellitus type 2
NM_017774.3(CDKAL1):c.371+11426A>C54901CDKAL1Uncertain significance10946398RCV000001037; NMedGen:C0011860,OMIM:125853,SNOMED CT:4405400662066103420661034NM_017774.3:c.371+11426A>CNC_000006.11:g.20661034A>COMIM Allelic Variant:611259.0001C0011860 125853 Diabetes mellitus type 2
NM_017774.3(CDKAL1):c.371+30101A>G54901CDKAL1Uncertain significance7756992RCV000001038; NMedGen:C0011860,OMIM:125853,SNOMED CT:4405400662067970920679709NM_017774.3:c.371+30101A>GNC_000006.11:g.20679709A>GOMIM Allelic Variant:611259.0002C0011860 125853 Diabetes mellitus type 2
NM_006208.2(ENPP1):c.517A>C (p.Lys173Gln)5167ENPP1Benign;risk factor1044498RCV000014559; RCV000014558; RCV000033192; RCV000178259; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C0028754,OMIM:601665,ORPHA:71529,SNOMED CT:414916001; MedGen:C1852091; MedGen:CN1693746132172368132172368NM_006208.2:c.517A>CNP_006199.2:p.Lys173GlnNC_000006.11:g.132172368A>COMIM Allelic Variant:173335.0006C0011860 125853 Diabetes mellitus type 2; C1852091 Insulin resistance, susceptibility to; CN169374 not specified; C0028754 601665 Obesity
NM_000160.4(GCGR):c.118G>A (p.Gly40Ser)2642GCGRPathogenic1801483RCV000017542; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006177976771579767715NM_000160.4:c.118G>ANP_000151.1:p.Gly40SerNC_000017.10:g.79767715G>AOMIM Allelic Variant:138033.0001C0011860 125853 Diabetes mellitus type 2
NM_001083112.2(GPD2):c.1904T>C (p.Phe635Ser)2820GPD2Pathogenic121918407RCV000017461; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540062157435621157435621NM_001083112.2:c.1904T>CNP_001076581.2:p.Phe635SerNC_000002.11:g.157435621T>COMIM Allelic Variant:138430.0001C0011860 125853 Diabetes mellitus type 2
NM_000545.6(HNF1A):c.1522G>A (p.Glu508Lys)6927HNF1Anot provided483353044RCV000122743; NMedGen:C0011860,OMIM:125853,SNOMED CT:4405400612121437091121437091NM_000545.6:c.1522G>ANP_000536.5:p.Glu508LysNC_000012.11:g.121437091G>A-C0011860 125853 Diabetes mellitus type 2
NM_000458.3(HNF1B):c.1395C>G (p.Ser465Arg)6928HNF1BPathogenic121918673RCV000013476; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006173606112736061127NM_000458.3:c.1395C>GNP_000449.1:p.Ser465ArgNC_000017.10:g.36061127G>COMIM Allelic Variant:189907.0007C0011860 125853 Diabetes mellitus type 2
NM_000457.4(HNF4A):c.1204G>A (p.Val402Ile)3172HNF4APathogenic137853337RCV000009793; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006204305704943057049NM_000457.4:c.1204G>ANP_000448.3:p.Val402IleNC_000020.10:g.43057049G>AOMIM Allelic Variant:600281.0004C0011860 125853 Diabetes mellitus type 2
NM_006548.4(IGF2BP2):c.239+29254C>A10644IGF2BP2risk factor4402960RCV000002537; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540063185511687185511687NM_006548.4:c.239+29254C>ANC_000003.11:g.185511687G>TOMIM Allelic Variant:608289.0001C0011860 125853 Diabetes mellitus type 2
NM_000208.3(INSR):c.3572G>A (p.Arg1191Gln)3643INSRPathogenic121913150RCV000015815; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540061971207187120718NM_000208.3:c.3572G>ANP_000199.2:p.Arg1191GlnNC_000019.9:g.7120718C>TOMIM Allelic Variant:147670.0021C0011860 125853 Diabetes mellitus type 2
NM_000208.3(INSR):c.3034G>A (p.Val1012Met)3643INSRBenign;Pathogenic;Uncertain significance1799816RCV000015822; RCV000175131; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:CN1693741971255187125518NM_000208.3:c.3034G>ANP_000199.2:p.Val1012MetOMIM Allelic Variant:147670.0029C0011860 125853 Diabetes mellitus type 2; CN169374 not specified
NM_005544.2(IRS1):c.1823C>G (p.Thr608Arg)3667IRS1Pathogenic104893642RCV000022626; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540062227661632227661632NM_005544.2:c.1823C>GNP_005535.1:p.Thr608ArgNC_000002.11:g.227661632G>COMIM Allelic Variant:147545.0003C0011860 125853 Diabetes mellitus type 2
NM_000525.3(KCNJ11):c.67A>G (p.Lys23Glu)3767KCNJ11Benign;drug response;risk factor5219RCV000009214; RCV000020356; RCV000009215; RCV000146116; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:C1833104,OMIM:606176; MedGen:C3152078; MedGen:CN169374111740957217409572NM_000525.3:c.67A>GNP_000516.3:p.Lys23GluNC_000011.9:g.17409572T>COMIM Allelic Variant:600937.0014C0011860 125853 Diabetes mellitus type 2; C3152078 Exercise stress response, impaired, association with; CN169374 not specified; C1833104 606176 Permanent neonatal diabetes mellitus
NM_005456.3(MAPK8IP1):c.176G>A (p.Ser59Asn)9479MAPK8IP1Pathogenic119489103RCV000005752; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006114591971045919710NM_005456.3:c.176G>ANP_005447.1:p.Ser59AsnNC_000011.9:g.45919710G>AOMIM Allelic Variant:604641.0001C0011860 125853 Diabetes mellitus type 2
NM_002500.4(NEUROD1):c.332G>T (p.Arg111Leu)4760NEUROD1Pathogenic104893649RCV000008303; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540062182543256182543256NM_002500.4:c.332G>TNP_002491.2:p.Arg111LeuNC_000002.11:g.182543256C>AOMIM Allelic Variant:601724.0001C0011860 125853 Diabetes mellitus type 2
NM_006193.2(PAX4):c.361C>T (p.Arg121Trp)5078PAX4Pathogenic114202595RCV000014800; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540067127254587127254587NM_006193.2:c.361C>TNP_006184.2:p.Arg121TrpNC_000007.13:g.127254587G>AOMIM Allelic Variant:167413.0001C0011860 125853 Diabetes mellitus type 2
NM_000340.1(SLC2A2):c.589G>A (p.Val197Ile)6514SLC2A2Pathogenic121909741RCV000017470; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540063170724960170724960NM_000340.1:c.589G>ANP_000331.1:p.Val197IleNC_000003.11:g.170724960C>TOMIM Allelic Variant:138160.0001C0011860 125853 Diabetes mellitus type 2
NM_001042.2(SLC2A4):c.1147G>A (p.Val383Ile)6517SLC2A4Uncertain significance121434581RCV000017469; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540061771890487189048NM_001042.2:c.1147G>ANP_001033.1:p.Val383IleNC_000017.10:g.7189048G>AOMIM Allelic Variant:138190.0001C0011860 125853 Diabetes mellitus type 2
NM_173851.2(SLC30A8):c.101_107delAAGATCA (p.Lys34Serfs)169026SLC30A8protective587777582RCV000129931; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540068118159222118159228NM_173851.2:c.101_107delAAGATCANP_776250.2:p.Lys34SerfsOMIM Allelic Variant:611145.0003C0011860 125853 Diabetes mellitus type 2
NM_173851.2(SLC30A8):c.412C>T (p.Arg138Ter)169026SLC30A8protective200185429RCV000129930; NMedGen:C0011860,OMIM:125853,SNOMED CT:440540068118165323118165323NM_173851.2:c.412C>TNP_776250.2:p.Arg138TerNC_000008.10:g.118165323C>TOMIM Allelic Variant:611145.0002C0011860 125853 Diabetes mellitus type 2
NM_030756.4(TCF7L2):c.382-41435C>T6934TCF7L2drug response7903146RCV000007838; RCV000211424; NMedGen:C0011860,OMIM:125853,SNOMED CT:44054006; MedGen:CN23652210114758349114758349NM_030756.4:c.382-41435C>TNC_000010.10:g.114758349C>TOMIM Allelic Variant:602228.0001,PharmGKB Clinical Annotation:1043858905,PharmGKB:1043858905C0011860 125853 Diabetes mellitus type 2; CN236522 sulfonamides, urea derivatives response - Efficacy
NM_030756.4(TCF7L2):c.483+7162G>C6934TCF7L2risk factor11196205RCV000007840; NMedGen:C0011860,OMIM:125853,SNOMED CT:4405400610114807047114807047NM_030756.4:c.483+7162G>CNC_000010.10:g.114807047G>COMIM Allelic Variant:602228.0003C0011860 125853 Diabetes mellitus type 2
NM_030756.4(TCF7L2):c.483+9017G>T6934TCF7L2risk factor12255372RCV000007839; NMedGen:C0011860,OMIM:125853,SNOMED CT:4405400610114808902114808902NM_030756.4:c.483+9017G>TNC_000010.10:g.114808902G>TOMIM Allelic Variant:602228.0002C0011860 125853 Diabetes mellitus type 2